Zobrazeno 1 - 10
of 83
pro vyhledávání: '"Yoshiyuki Takahashi"'
Autor:
Hiroyuki Shimada, Akihiko Tanizawa, Takeshi Kondo, Tokiko Nagamura-Inoue, Masahiro Yasui, Arinobu Tojo, Hideki Muramatsu, Tetsuya Eto, Noriko Doki, Masatsugu Tanaka, Maho Sato, Maiko Noguchi, Naoyuki Uchida, Yoshiyuki Takahashi, Naoki Sakata, Tatsuo Ichinohe, Yoshiko Hashii, Koji Kato, Yoshiko Atsuta, Kazuteru Ohashi
Publikováno v:
Transplantation and Cellular Therapy. 28:376-389
The breakthrough effects of tyrosine kinase inhibitors (TKIs) have lessened indications for allogeneic hematopoietic stem cell transplantation (HSCT) in chronic myeloid leukemia (CML). However, HSCT is still attractive for children and adolescents/yo
Autor:
Masahide Yamamoto, Maho Sato, Yasushi Onishi, Yoji Sasahara, Hideki Sano, Masayoshi Masuko, Hirohisa Nakamae, Ken‐ichi Matsuoka, Takahide Ara, Kana Washio, Makoto Onizuka, Kenichiro Watanabe, Yoshiyuki Takahashi, Tsuneaki Hirakawa, Miwako Nishio, Chizuko Sakashita, Tohru Kobayashi, Akihisa Sawada, Tatsuo Ichinohe, Takahiro Fukuda, Yoshiko Hashii, Yoshiko Atsuta, Ayako Arai
Publikováno v:
American Journal of Hematology. 97:780-790
The effects of allogeneic hematopoietic stem cell transplantation (allo-HSCT) on systemic chronic active Epstein-Barr virus infection (sCAEBV) are yet to be analyzed in a large number of patients. Using the Japanese registry database, Transplant Regi
Autor:
Hisashi Ishida, Motohiro Kato, Yuta Kawahara, Sae Ishimaru, Yuho Najima, Shinichi Kako, Maho Sato, Mitsuteru Hiwatari, Maiko Noguchi, Keisuke Kato, Katsuyoshi Koh, Keiko Okada, Fuminori Iwasaki, Ryoji Kobayashi, Shunji Igarashi, Shoji Saito, Yoshiyuki Takahashi, Atsushi Sato, Junji Tanaka, Yoshiko Hashii, Yoshiko Atsuta, Hirotoshi Sakaguchi, Toshihiko Imamura
Publikováno v:
Hematological Oncology. 40:457-468
Acute lymphoblastic leukemia (ALL) is the most common cancer during childhood, and some high-risk patients with ALL require hematopoietic stem cell transplantation (HSCT). Mainly due to small patient numbers, studies focusing specifically on children
Autor:
Maho Sato, Tomohiro Morio, Hiromasa Yabe, Akira Nishimura, Koji Kato, Yoshiyuki Takahashi, Masami Inoue, Satoshi Miyamoto, Takashi Koike, Akihiro Iguchi, Kohsuke Imai, Tomonari Shigemura, Yoshiko Atsuta, Yoji Sasahara, Michiko Kajiwara, Masakatsu Yanagimachi, Motohiro Kato, Yoshiko Hashii, Mio Kurata, Masataka Ishimura, Katsutsugu Umeda
Publikováno v:
Journal of Clinical Immunology
Purpose Hematopoietic cell transplantation (HCT) is a curative therapy for patients with severe combined immunodeficiency (SCID). Here, we conducted a nationwide study to assess the outcome of SCID patients after HCT in Japan. Methods A cohort of 181
Autor:
Asahito Hama, Nozomu Kawashima, Motoharu Hamada, Nobuhiro Nishio, Seiji Kojima, Eri Nishikawa, Shinji Nakao, Yusuke Okuno, Daisuke Ichikawa, Hideki Muramatsu, Kyogo Suzuki, Hirohito Yamazaki, Yoshiyuki Takahashi, Atsushi Narita
Publikováno v:
European Journal of Haematology. 107:255-264
Objectives Patients with acquired aplastic anemia (AA) without HLA-matched sibling donors or aged >40 years receive immunosuppressive therapy (IST) with anti-thymocyte globulin (ATG). We investigated the relationship between plasma rabbit ATG (r-ATG)
Autor:
Toshiki Nakane, Tomohiko Nakata, Yu Okai, Hisashi Kawai, Masaharu Tanaka, Hiroyuki Kidokoro, Yoko Sakaguchi, Yoshiyuki Takahashi, Toshiaki Taoka, Jun Natsume, Hiroyuki Yamamoto, Yuji Ito, Hideki Muramatsu, Atsuko Ohno, Shinji Naganawa
Publikováno v:
Pediatric Neurology. 111:78-84
Background Advances in hematopoietic stem cell transplantation have improved the survival rate of malignant diseases and congenital immunodeficiencies. It has become important to assess long-term complications in survivors. To assess neurological abn
Autor:
Ken Tabuchi, Atsushi Ogawa, Yoshiyuki Takahashi, Atsushi Kikuta, Koji Kato, Yuhki Koga, Masami Inoue, Yoshiko Hashii, Katsuyoshi Koh, Kimikazu Matsumoto, Ryoji Kobayashi, Junichi Hara
Publikováno v:
Journal of Pediatric Hematology/Oncology. 42:251-255
Background Almost all pediatric patients with renal tumors are diagnosed with nephroblastoma (Wilms tumor), clear cell sarcoma, or malignant rhabdoid tumor. The choice of treatment is important for relapsed and refractory patients with nephroblastoma
Autor:
Tetsushi Yoshikawa, Toshiyuki Fukao, Yoshiyuki Takahashi, Hirokazu Kurahashi, Shinji Saitoh, Hideyuki Iwayama, Masahiro Hirayama, Jun Natsume, Shingo Numoto, Akihisa Okumura
Publikováno v:
Pediatrics International. 62:337-340
Background An outbreak of acute flaccid myelitis was chronologically correlated with an outbreak of severe respiratory illness in Japan in 2015. We hypothesized that increases in children hospitalized with severe respiratory illnesses might also be a
Autor:
Masao Kobayashi, Yuko Cho, Tomohiro Morio, Hiromasa Yabe, Kohsuke Imai, Katsutsugu Umeda, Masami Inoue, Nao Yoshida, Yoshiko Hashii, Michiko Kajiwara, Masakatsu Yanagimachi, Yoshiko Atsuta, Yoshiyuki Takahashi
Publikováno v:
International Journal of Hematology. 111:869-876
The impact of acute and chronic graft-versus-host disease (GVHD) on clinical outcomes was retrospectively analyzed in 960 patients with non-malignant diseases (NMD) who underwent a first allogeneic hematopoietic stem cell transplantation (HSCT). Grad
Autor:
Kazue Nozawa, Asahito Hama, Masao Kobayashi, Hideki Muramatsu, Daisuke Hasegawa, Katsuyoshi Koh, Kenichiro Watanabe, Masafumi Ito, Yoshiyuki Kosaka, Atsushi Manabe, Yoshiyuki Takahashi, Atsushi Narita, Akira Ohara, Seiji Kojima
Publikováno v:
British journal of haematologyReferences. 196(4)
In 2008, the World Health Organization proposed a new entity of childhood myelodysplastic syndrome (MDS), which was referred to as refractory cytopenia of childhood (RCC). However, whether this morphological classification reflects clinical outcomes